Literature DB >> 2347475

Indocyanine green (ICG) test before and after exercise in patients with chronic liver diseases.

M Nambu1, T Iijima.   

Abstract

The indocyanine green (ICG) test (serum disappearance rate: K and 15 min. retention rate: R15) was performed in 15 patients with chronic hepatitis (CH) and 22 patients with liver cirrhosis (LC) before and after exercise (Master's two step method for three min.). In LC, ICG K was 0.063 +/- 0.026 (mean +/- SD) before exercise and 0.083 +/- 0.028 after exercise. ICG R15 was 31.6 +/- 15.6% and 23.3 +/- 15.3%, respectively. In CH, ICG R15 before exercise was 8.2 +/- 4.0%, as compared with that (5.7 +/- 3.6%) after exercise. Namely, the ICG test significantly (P less than 0.05) improved after exercise in chronic liver diseases. Excretion of ICG into bile after exercise increased both in gallstone patients without abnormal liver function and LC, and it markedly increased in patients with decompensated LC. There was no significant difference in ICG excreted into urine before and after exercise. These results suggest that hepatic blood flow increases through moderate exercise in chronic liver diseases.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2347475     DOI: 10.1007/bf02776818

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  11 in total

1.  The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function.

Authors:  J CAESAR; S SHALDON; L CHIANDUSSI; L GUEVARA; S SHERLOCK
Journal:  Clin Sci       Date:  1961-08       Impact factor: 6.124

2.  Studies of hepatic function with indocyanine green.

Authors:  D B HUNTON; J L BOLLMAN; H N HOFFMAN
Journal:  Gastroenterology       Date:  1960-12       Impact factor: 22.682

3.  Hepatic uptake and biliary excretion of indocyanine green in the dog.

Authors:  H O WHEELER; W I CRANSTON; J I MELTZER
Journal:  Proc Soc Exp Biol Med       Date:  1958-10

4.  Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction.

Authors:  G R CHERRICK; S W STEIN; C M LEEVY; C S DAVIDSON
Journal:  J Clin Invest       Date:  1960-04       Impact factor: 14.808

5.  The effect of exercise on the splanchnic blood flow and splanchnic blood volume in normal man.

Authors:  S E BRADLEY; A W CHILDS; B COMBES; A COURNAND; O L WADE; H O WHEELER
Journal:  Clin Sci       Date:  1956-08       Impact factor: 6.124

6.  Variations in hepatic blood flow in man during health and disease.

Authors:  S E BRADLEY
Journal:  N Engl J Med       Date:  1949-03-24       Impact factor: 91.245

7.  Changes of splanchnic circulation with progression of chronic liver disease studied by echo-Doppler flowmetry.

Authors:  K Ohnishi; S Sato; D Pugliese; T Tsunoda; M Saito; K Okuda
Journal:  Am J Gastroenterol       Date:  1987-06       Impact factor: 10.864

8.  [Measurement of portal blood flow and effective hepatic circulation in liver cirrhosis--influence of glucagon].

Authors:  M Itakura
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1986-07

9.  Effects of propranolol and exercise on cardiac dynamics and organ blood flow distribution in dogs.

Authors:  L Dumont; P Magrassi; R Parent; P Stanley; C Chartrand
Journal:  J Auton Pharmacol       Date:  1984-12

Review 10.  Effect of acute and chronic exercise on hepatic drug metabolism.

Authors:  M Døssing
Journal:  Clin Pharmacokinet       Date:  1985 Sep-Oct       Impact factor: 6.447

View more
  4 in total

1.  Quantified Risk Assessment for Major Hepatectomy via the Indocyanine Green Clearance Rate and Liver Volumetry Combined with Standard Liver Volume.

Authors:  Shin Hwang; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Chul-Soo Ahn; Deok-Bog Moon; Ki-Hun Kim; Young-Joo Lee; Sung-Gyu Lee
Journal:  J Gastrointest Surg       Date:  2015-05-07       Impact factor: 3.452

2.  Indocyanine green clearance varies as a function of N-acetylcysteine treatment in a murine model of acetaminophen toxicity.

Authors:  Alessandra Milesi-Hallé; Susan M Abdel-Rahman; Aliza Brown; Sandra S McCullough; Lynda Letzig; Jack A Hinson; Laura P James
Journal:  Chem Biol Interact       Date:  2010-12-09       Impact factor: 5.192

3.  Relationship between liver function and splenic blood flow (quantitative measurement of splenic blood flow with H2(15)O and a dynamic state method: 2).

Authors:  A Oguro; H Taniguchi; H Koyama; H Tanaka; K Miyata; K Takeuchi; T Inaba; H Nakahashi; T Takahashi
Journal:  Ann Nucl Med       Date:  1993-11       Impact factor: 2.668

Review 4.  Clinical pharmacokinetic and pharmacodynamic considerations in patients with liver disease. An update.

Authors:  D J Morgan; A J McLean
Journal:  Clin Pharmacokinet       Date:  1995-11       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.